Skip to main content
SpringerLink
Log in

(Neo-)adjuvante medikamentöse Therapie

  • Chapter
Weichgewebetumoren

Zusammenfassung

Weichgewebesarkome des Erwachsenen stellen diagnostisch anspruchsvolle und therapeutisch komplexe Erkrankungen dar. Die Heterogenität mit diversen, biologisch sehr differenten histologischen Subtypen, verbunden mit der Seltenheit der Erkrankung, behindert das Fortschreiten des Erkenntnisgewinns. In den letzten Jahren, generiert durch die molekulare Pathologie, wurde evident, dass das »Sammelsurium Weichgewebesarkome« eigenständige Entitäten beinhaltet, die differenzierte Therapieansätze benötigen. Dieser Wissensgewinn hat sich in der Mehrzahl der »adult type sarcomas« mit komplexen, heterogenen Genomveränderungen noch nicht in neue Therapieansätze transferieren lassen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bauer HC, Trovik CS, Alvegard TA et al. (2001) Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 72:150–159

    Article  PubMed  CAS  Google Scholar 

  • Bauer S, Hartmann JT (2006) Locally advanced and metastatic sarcoma (adult type) including gastrointestinal stromal tumors (GIST). Crit Rev Oncol Hematol 60:112–130

    Article  PubMed  Google Scholar 

  • Billingsley KG, Lewis JJ, Leung DH et al. (1999) Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer 85:389–395

    Article  PubMed  CAS  Google Scholar 

  • Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K; American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team (2009) Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 28;373(9669):1097–104

    Google Scholar 

  • Dienemann H, Schneider T (2009) Intrathorakale onkologische Notfälle. Indikation zur chirurgischen Therapie und operatives Konzept. Onkologe 15:389–398

    Article  Google Scholar 

  • Eilber FC, Brennan MF, Eilber FR et al. (2007) Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg 246:105–113

    Article  PubMed  Google Scholar 

  • Eilber FC, Eilber FR, Eckardt J et al. (2004) The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg 240:686–695

    PubMed  Google Scholar 

  • Eilber FC, Rosen G, Eckardt J et al. (2001) Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19:3203–3209

    PubMed  CAS  Google Scholar 

  • Gortzak E, Azzarelli A, Buesa J et al. (2001) A randomised phase II study on neo-adjuvant chemotherapy for ‚high-risk‘ adult soft-tissue sarcoma. Eur J Cancer 37:1096–1103

    Article  PubMed  CAS  Google Scholar 

  • Grobmyer SR, Maki RG, Demetri GD et al. (2004) Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 15:1667–1672

    Article  PubMed  CAS  Google Scholar 

  • Hartmann JT, Oechsle K, Brugger W et al. (2004) Phase II of neoadjuvant dose-intensive chemotherapy with adriamycin and ifosfamide followed by high-dose ICE in locally advanced soft tissue sarcomasol. Ann Oncol 15 (Suppl 3):198–199 (abstract 752)

    Google Scholar 

  • Hartmann JT, Schütte J (2009) Neoadjuvante Chemotherapie des lokalisierten Weichteilsarkoms. Onkologe 15:389–397

    Article  Google Scholar 

  • Hartmann JT, Thiess F, Kluba T et al. (2008) Factors associated with the suboptimal treatment of patients with soft tissue sarcoma (STS). Onkologie 31 (Suppl 4):588

    Google Scholar 

  • Hartmann JT, von Weyhern CH, Couchon R, Königsrainer A, Kluba T, de Zwart P, Frickhofen N, Wolf A, Fend F, Budach V (2010) Interim analysis of a cooperative registry to optimize neoadjuvante treatment for large sized, high-grade non-rhabdomyo (soft tissued) sarcoma (NRSTS) following R0/1-resection (IAWS-2), Onkologie (im Druck)

    Google Scholar 

  • Hoos A, Lewis JJ, Brennan MF (2000) Soft tissue sarcoma: prognostic factors and multimodal treatment. Chirurg 71:787–794

    Article  PubMed  CAS  Google Scholar 

  • Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, Abdel- Rahman S, Daugaard S, Salat C, Wendtner cm, Vujaskovic Z, Wessalowski R, Jauch KW, Dürr HR, Ploner F, Baur-Melnyk A, Mansmann U, Hiddemann W, Blay JY, Hohenberger P; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG); European Society for Hyperthermic Oncology (ESHO) (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11(6):561–570

    Google Scholar 

  • Italiano A, Delva F, Mathoulin-Pelissier S, Le Cesne A, Bonvalot S, Terrier P, Trassard M, Michels JJ, Blay JY, Coindre JM, Bui B (2010) Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database. Ann Oncol [Epub ahead of print]

    Google Scholar 

  • Italiano A, Penel N, Robin YM, Bui B, Le Cesne A, Piperno-Neumann S, Tubiana-Hulin M, Bompas E, Chevreau C, Isambert N, Leyvraz S, du Chatelard PP, Thyss A, Coindre JM, Blay JY (2009) Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. Ann Oncol 20(3):425–430

    Article  PubMed  CAS  Google Scholar 

  • Kraybill WG, Harris J, Spiro IJ et al. (2006) Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 24:619–625

    Article  PubMed  CAS  Google Scholar 

  • Kraybill WG, Harris J, Spiro IJ, Ettinger DS, Delaney TF, Blum RH, Lucas DR, Harmon DC, Letson GD, Eisenberg B (2010) Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: radiation Therapy Oncology Group Trial 9514. Cancer Jun 22 [Epub ahead of print]

    Google Scholar 

  • Lewis JJ, Leung D, Espat J, Woodruff JM, Brennan MF (2000) Effect of reresection in extremity soft tissue sarcoma. Ann Surg 231:655–663

    Article  PubMed  CAS  Google Scholar 

  • Meric F, Milas M, Hunt KK et al. (2000) Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol 18:3378–3383

    PubMed  CAS  Google Scholar 

  • Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130:1466–1478

    PubMed  CAS  Google Scholar 

  • O'Connor JM, Chacon M, Petracci FE, Chacon RD (2008) Adjuvant chemotherapy in soft tissue sarcoma (STS): A meta-analysis of published data. J Clin Oncol 26:10526 (abstract)

    Google Scholar 

  • Pervaiz N, Colterjohn N, Farrokhyar F et al. (2008) A systematic metaanalysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113:573–581

    Article  PubMed  Google Scholar 

  • Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14:1679–1689

    PubMed  CAS  Google Scholar 

  • Rosenberg SA, Tepper J, Glatstein E et al. (1982) The treatment of soft- tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196:305–315

    Article  PubMed  CAS  Google Scholar 

  • Stojadinovic A, Leung DH, Hoos A et al. (2002) Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 235:424–434

    Article  PubMed  Google Scholar 

  • Woll PJ, Van Glabbeke M, Hohenberger P, le Cesne A, Gronchi A (2007) EORTC Soft Tissue & Bone Sarcoma Group. Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): Interim analysis of a randomised phase III trial. J Clin Oncol 25:10008 (abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Comprehensive Cancer Center Nord, Universitätsklinikum Schleswig Holstein Campus Kiel, Arnold-Heller-Straße 3, 24105, Kiel

    Prof. Dr. med. Jörg T. Hartmann

  2. Klinik für Onkologie und Hämatologie, Marien Hospital Düsseldorf, Rochusstraße 2, 40479, Düsseldorf

    Prof. Dr. med. Jochen Schütte

Authors
  1. Prof. Dr. med. Jörg T. Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Jochen Schütte
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hartmann, J.T., Schütte, J. (2011). (Neo-)adjuvante medikamentöse Therapie. In: Weichgewebetumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04939-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04939-2_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04938-5

  • Online ISBN: 978-3-642-04939-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation